Internal Medicine, Infectious Disease · New York, NY
NPI
1811089972
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 10th Ave
New York, NY, 10019
Phone (212) 523-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
142 services
Medicare patients, 2024
61
Average age 70
Drug cost, 2024
$5.4M
7,695 prescriptions
Company payments, 2025
$25.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luz A Lugo was code 99214 (office e&m - established), 109 times for 36 patients. In total Luz A Lugo billed 142 services in 7 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 109 | 36 | $73.09 | $7,967 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $149.98 | $2,100 |
By year: 2022 $12K for 147 services; 2023 $12K for 151 services; 2024 $12K for 142 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luz A Lugo prescribed most often to Medicare patients was Atorvastatin Calcium, with 428 prescriptions and refills. In total Luz A Lugo wrote 7,695 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 428 | 665 | 78 | $1,992 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 313 | 319 | 41 | $1.2M |
| Amlodipine Besylate Generic | 226 | 272 | 30 | $463 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 204 | 214 | 27 | $726K |
| Valacyclovir Valacyclovir Hcl | 203 | 225 | 27 | $3,690 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 201 | 210 | 31 | $6,793 |
| Tivicay Dolutegravir Sodium | 198 | 202 | 20 | $508K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 191 | 202 | 22 | $112 |
| Descovy Emtricitabine/Tenofov Alafenam | 179 | 183 | 22 | $370K |
| Gabapentin Generic | 168 | 190 | 25 | $1,190 |
| Lisinopril Generic | 168 | 259 | 30 | $665 |
| Metoprolol Succinate Generic | 155 | 171 | 21 | $920 |
| Ammonium Lactate Generic | 139 | 150 | 20 | $1,748 |
| Metformin Hcl Generic | 130 | 236 | 23 | $672 |
| Zolpidem Tartrate Generic | 129 | 129 | 18 | $496 |
Brand drugs: 2,328 claims; generic drugs: 5,216 claims; opioid claims: 201.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luz A Lugo $25.7 ($25.7 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $25.7.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $25.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.